Video Experimental Relacionado
Updated: Aug 1, 2026
09:12
Channelrhodopsin2 Mediated Stimulation of Synaptic Potentials at Drosophila Neuromuscular Junctions
Published on: March 16, 2009
Formación de la sinapsis de Drosophila: regulación por la proteína transmembrana con repeticiones ricas en Leu,
E Shishido1, M Takeichi, A Nose
1National Institute for Basic Biology, Myodaiji-cho, Okazaki 444-8585, Japan.
Science (New York, N.Y.)
|June 26, 1998
Resumen
El gen capricho (caps) en la Drosophila regula la selección del objetivo del cono de crecimiento neuronal. La pérdida de la función de las tapas interrumpe la formación de sinapsis selectivas, destacando su papel en la especificidad del cableado neuronal.
Área de la Ciencia:
- La neurociencia es la neurociencia.
- Biología del desarrollo Biología del desarrollo.
- Genética La genética.
Sus antecedentes:
- Los conos de crecimiento neuronal navegan a las regiones objetivo, seleccionando socios específicos para la formación de sinapsis.
- El gen Drosophila capricious (caps) codifica una proteína transmembrana con repeticiones ricas en leucina (LRR).
Objetivo del estudio:
- Para investigar el papel del gen Drosophila capricious (caps) en la formación selectiva de sinapsis.
- Comprender cómo los caps influyen en la especificidad del objetivo durante el desarrollo neuronal.
Principales métodos:
- Estudió el patrón de expresión de las tapas durante el desarrollo de la sinapsis neuromuscular en Drosophila.
- Se analizaron los efectos de la pérdida de función de las tapas y la expresión ectópica en la especificidad del objetivo de las motoneuronas.
Principales resultados:
- Caps se expresa en socios sinápticos específicos, incluido el músculo 12 y sus motoneuronas innervantes.
- Los niveles alterados de expresión de las tapas (pérdida de función y ectópico) modifican la selección objetivo de las neuronas motoras del músculo 12.
Conclusiones:
- El gen Drosophila caps juega un papel crucial en la regulación de la especificidad de la formación de sinapsis.
- Caps actúa como un determinante molecular para el cableado neuronal selectivo durante el desarrollo.
Videos de Conceptos Relacionados
02:23SN2 Reaction: Stereochemistry
In an SN2 reaction, the nucleophilic attack on the substrate and departure of the leaving group occurs simultaneously through a transition state. As the nucleophile approaches the substrate from the back-side, the configuration of the substrate carbon changes from tetrahedral to trigonal bipyramidal and then back to tetrahedral, leading to an inversion in the configuration of the product.
If the substrate is an achiral molecule at the α-carbon, the inversion of configuration is not observed.
If the substrate is an achiral molecule at the α-carbon, the inversion of configuration is not observed.
01:29Reaction Mechanisms: Rate-limiting Step Approximation
The rate-determining step, or RDS, in a chemical reaction is the slowest step that determines the overall reaction rate. It is identified by using the observed rate law and typically involves approximation methods like the RDS approximation or the steady-state approximation.In the RDS approximation, also known as the rate-limiting-step or equilibrium approximation, the reaction mechanism consists of one or more reversible reactions near equilibrium, followed by a slower RDS, and then one or...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...